Clinical Trial Update: Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combined anti-platelet and anti-coagulation therapy after thrombolysis for ischemic stroke; the study is completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Ischemic Stroke | Phase 2 | Status: COMPLETED | Results posted: 2013-02-04